证券代码:002178 编号:2016-010 证券简称:延华智能 活动记录表 上海延华智能科技《集团）股份有限公司 | --- | --- | --- | |-------------------------|-----------------------------|-------------------------------------------------------------------------------------------------------------------| | | | | | 投资者关系活动 | 团特定对象调研 | □分析师会议 | | 类别 | □媒体采访 | □业绩说明会 | | | 口新闻发布会 | □路演活动 | | | □现场参观 | 口其他 (请文字说明其他活动内容) | | 参与单位名称及 人员姓名 | 资本:候静海。 | 德邦证券:汪翊、饶璐、梁斌、李靓、马文靓:东方证券:阎诚泉; 香溢融通:陈晔、陈力、仇晓南、施力楠;钦林资管:陆晓俊;伊金 | | 时间 | 2016年5月17日15:00 | | | | | | | 地点 | | 上海市普陀区西康 ...

Group 1: Smart Medical Projects - The Chongzhou "Smart Medical" project aims to create a city-level smart medical cloud platform, integrating fragmented medical data into a unified health data cloud platform [2] - The project will provide services such as software platform construction, data interface setup, and operational maintenance for the local health authority [2] - The completion of the Chongzhou medical information platform will facilitate real-time data transmission among various medical institutions [2] Group 2: National Smart City Network - The company collaborates with local state-owned platforms to establish joint ventures for smart city construction and operation [3] - Existing smart city companies include Wuhan, Zunyi, Gui'an, and others, with plans to expand to provincial capitals and surrounding areas [3] - The "Smart City Model" allows the company to leverage local resources and quickly enter local markets [3] Group 3: Smart Medical Industry Chain Development - The company focuses on strategic investments to extend the smart medical industry chain, emphasizing hospital and regional medical information platforms [4] - Future plans include exploring remote medical platforms and data mining projects [4] - The company aims to enhance its core competitiveness through acquisitions in the smart medical sector [4] Group 4: Business Differentiation and Acquisitions - Chengdian Yixing focuses on comprehensive information products for hospitals, covering over 1,600 hospitals across 17 provinces [5] - Meidi Xilan emphasizes regional medical platforms, integrating advanced IT technologies with health applications [5] - The acquisition of Chengdian Yixing and Meidi Xilan enhances the company's capabilities in hospital information and regional medical platform development [5] Group 5: Infection Control and Traceability - Ganxin Information specializes in providing traceable disinfection supply systems (CSSD) for hospitals, covering over 200 top-tier hospitals with a market share of approximately 40% [6] - The company aims to create a comprehensive traceability service platform connecting various stakeholders in the healthcare supply chain [6] Group 6: Elderly Care and Health Management - The Changchun Elderly Care Comprehensive Cloud Information Platform includes 1 elderly care institution and 379 home care service centers [7] - This project positions the company in the health management sector, integrating medical and elderly care services [7] Group 7: Performance Expectations and Business Strategy - The company anticipates steady growth in the second half of 2016, supported by performance commitments from acquisitions [8] - The smart medical and energy-saving sectors are expected to strengthen, providing new profit growth points [8] - The smart energy sector focuses on energy efficiency and green facility management services [8] Group 8: Environmental Protection Initiatives - The company actively explores business strategies in environmental protection, focusing on air and water management [9] - A joint venture for smart environmental technology has been established to enhance resource sharing and service capabilities [9] - The company has secured contracts worth 11.42 million yuan in the first half of the year, laying a solid foundation for profit contributions [9] Group 9: PPP Project Exploration - The company is exploring opportunities to undertake PPP projects, particularly in smart medical facility construction [10] - There is an expectation for deeper cooperation with local governments through the PPP model [10] Group 10: Smart Building Business - Although the smart building business is declining in proportion, it still represents a significant revenue source [10] - The company plans to maintain a stable growth rate of 20%-30% in the smart building sector while enhancing investments in smart medical and environmental businesses [10]

证券代码：002178 证券简称：延华智能 上海延华智能科技（集团）股份有限公司 投资者关系活动记录表 编号：2019－001 | --- | --- | --- | --- | |-----------------|-----------------------------------|------------------------------------------|----------------------------------------------------| | | ☑ | 特定对象调研 □分析师会议 | | | 投资者关系 | □ 媒体采访 □业绩说明会 | | | | 活动类别 | □ 新闻发布会 □路演活动 | | | | | □ 现场参观 | □ | 其他 （请文字说明其他活动内容） | | 参与单位名称 | 华融津投： 3 人 | | | | 及人员姓名 | 华融置业：1 人 个人股东：胡黎明 | | | | 时间 | 2019 年 7 月 26 | 日 10:00 | | | 地点 | 上海市普陀区西康路 | 1255 | 号普陀科技大厦 17 楼会议室 | | | | | 董 ...

Group 1: Company Performance and Strategy - The company reported profitability in 2019 and 2021, but faced challenges in recent years due to various factors, including the COVID-19 pandemic and goodwill impairment of subsidiaries [2][3]. - In 2022, the company aims to focus on "smart city, smart healthcare construction, operation, and service" as its strategic positioning, providing comprehensive lifecycle construction, operation, and management services [2][3]. - The company plans to enhance its competitive edge in the smart city sector by leveraging technology and industry experience, aiming for a sustainable future [3][4]. Group 2: Impact of COVID-19 - The COVID-19 pandemic has affected project timelines, with some construction and acceptance processes experiencing delays [6][7]. - The company has actively participated in pandemic control efforts, developing platforms to assist users in managing on-site operations and reducing cross-infection risks [5][8]. - The impact of the pandemic on the company's second-quarter revenue remains uncertain, with ongoing monitoring of the situation [6][7]. Group 3: Investor Relations and Market Sentiment - The company's stock price fluctuations are influenced by multiple factors, including policy changes, market sentiment, and industry conditions [2]. - The company is in communication with major shareholders regarding equity transfer matters, but no further developments have been reported as of the meeting date [2][3]. - The company emphasizes the importance of rational investment and risk awareness among investors [2]. Group 4: Future Plans and Innovations - The company is committed to advancing its "1+3+5" development strategy in healthcare big data and enhancing the "Yanhua Cloud Platform" [4][5]. - Plans include exploring mergers and acquisitions to extend the industry chain and improve overall service capabilities [4][5]. - The company is focusing on digital transformation and green development as part of its strategic goals [4][5].

证券代码： 002178 证券简称：延华智能 上海延华智能科技(集团)股份有限公司 投资者关系活动记录表 | --- | --- | --- | |--------------------------|--------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | 投资者关系 活动类别 | □ 特定对象调研 □ \n□ 媒体采访 √ \n□ 新闻发布会 \n□ 现场参观 \n□ 其他 | 分析师会议 \n 业绩说明会 \n □ 路演活动 \n（请文字说明其他活动内容） | ...

Financial Performance - The company's revenue for Q3 2022 was ¥153,826,960.56, a decrease of 27.17% compared to the same period last year[3] - The net profit attributable to shareholders was ¥6,975,318.85, down 31.19% year-on-year, while the net profit after deducting non-recurring gains and losses was a loss of ¥3,460,308.32, a decrease of 143.90%[3] - The basic earnings per share were ¥0.0098, down 30.99% compared to the same period last year[3] - The net profit for Q3 2022 was -11,349,088.86 CNY, compared to a net profit of 2,450,039.38 CNY in the same period last year, indicating a significant decline[30] - Operating profit for the quarter was -11,081,262.55 CNY, down from 17,624,904.10 CNY year-over-year[30] - The company reported a total comprehensive loss of -11,349,088.86 CNY for the quarter, compared to a comprehensive income of 2,450,039.38 CNY in the previous year[30] - The basic and diluted earnings per share were both -0.0122 CNY, compared to 0.0038 CNY in the same period last year[30] Cash Flow and Assets - Cash flow from operating activities showed a net outflow of ¥79,315,647.88, reflecting a 17.04% increase in outflow compared to the previous year[3] - The company's cash and cash equivalents decreased to CNY 271,227,421.41 from CNY 392,853,687.92 at the beginning of the year, representing a decline of 30.8%[22] - The cash and cash equivalents at the end of the period were 258,488,413.66 CNY, down from 290,784,481.39 CNY at the end of the same quarter last year[32] - Investment activities resulted in a net cash outflow of -33,888,248.48 CNY, compared to -12,244,445.27 CNY in the previous year[32] - Financing activities generated a net cash outflow of -12,092,823.82 CNY, a decrease from a net inflow of 52,479,428.53 CNY in the same quarter last year[32] Operating Performance - The company reported a 34.81% decrease in operating income year-to-date, attributed to project delays caused by the pandemic[8] - Total operating revenue for Q3 2022 was CNY 371,241,971.28, a decrease of 34.8% compared to CNY 569,492,116.48 in the same period last year[28] - Total operating costs for Q3 2022 were CNY 389,502,112.52, down 33.5% from CNY 587,313,914.79 year-on-year[28] Shareholder Information - Total number of common shareholders at the end of the reporting period is 71,856[11] - The largest shareholder, Huarong (Tianjin Free Trade Zone) Investment Co., holds 17.41% of shares, totaling 123,983,721 shares[11] - Shareholder Hu Liming holds 9.46% of shares, totaling 67,389,137 shares, with a new plan to reduce holdings by up to 6% of total shares[15] - The top ten shareholders hold a significant portion of shares, with the top three alone accounting for over 36%[11] - There are no reported financing or margin trading activities among the top ten shareholders[11] Asset Management - The total assets at the end of the reporting period were ¥1,645,367,731.12, representing a decrease of 7.06% from the end of the previous year[3] - Total assets decreased to CNY 1,645,367,731.12 from CNY 1,770,309,347.04, a decline of 7.1%[26] - Total liabilities decreased to CNY 922,005,860.13 from CNY 1,034,198,387.19, a reduction of 10.8%[26] - Accounts receivable increased to CNY 379,244,583.92 from CNY 352,812,171.70, reflecting a growth of 7.5%[22] - Inventory rose to CNY 87,316,661.31, up 28.1% from CNY 68,149,882.74 at the beginning of the year[22] Corporate Governance - The company has initiated legal action against the performance guarantee party Zhonghui Qianding for failing to meet performance commitments related to its associate company Taihe Kang[13] - The company has appointed a new non-independent director, Cao Lei, to the board, effective upon shareholder approval[18] - The company’s board has approved the hiring of several senior executives, including Cao Lei as CFO and Shi Xuequn as Executive Vice President[18] Investment and Financing Activities - The company experienced a 100% decrease in trading financial assets due to the redemption of bank wealth management products[7] - The company’s long-term deferred expenses decreased by 33.27% due to the amortization of renovation costs by subsidiaries[7] - The company’s investment income decreased by 107.87% year-on-year, primarily due to reduced earnings from long-term equity investments accounted for using the equity method[9] - The company’s cash flow from financing activities decreased by 123.04%, mainly due to increased repayments of bank loans compared to the previous year[9] - The company provided guarantees for its subsidiary Shanghai Oriental Yanhua, securing loans of CNY 5 million from Shanghai Rural Commercial Bank and CNY 5 million from Bank of China[19] Legal and Regulatory Matters - The company reached a settlement agreement regarding construction project disputes with Yunnan Yaguang Media Development Co., Ltd.[21] - The company responded to an inquiry letter from the Shenzhen Stock Exchange regarding various matters[20] - There are ongoing discussions regarding the repurchase of shares from the performance guarantee party due to unmet commitments[13] Product and Technology Development - The company has not disclosed any new product or technology developments in the recent reports[12]

Financial Performance - The company's operating revenue for the first half of 2022 was ¥217,415,010.72, a decrease of 39.32% compared to ¥358,287,210.65 in the same period last year[20]. - The net profit attributable to shareholders was a loss of ¥15,684,499.30, worsening by 111.95% from a loss of ¥7,400,236.31 in the previous year[20]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was a loss of ¥18,153,243.57, an increase of 104.18% compared to a loss of ¥8,890,625.84 last year[20]. - The net cash flow from operating activities was a negative ¥90,525,933.52, showing an improvement of 11.00% from a negative ¥101,709,432.62 in the previous year[20]. - Total assets at the end of the reporting period were ¥1,641,497,040.74, down 7.28% from ¥1,770,309,347.04 at the end of the previous year[20]. - The net assets attributable to shareholders decreased by 2.70% to ¥555,934,766.44 from ¥571,384,459.72 at the end of the previous year[20]. - The weighted average return on net assets was -2.78%, a decrease of 1.46% from -1.32% in the previous year[20]. - The company reported a significant increase in financial expenses by 834.16% to CNY 3.17 million, primarily due to interest income recognition from a legal dispute[54]. - The company's revenue for the first half of 2022 was CNY 217.42 million, a decrease of 39.32% compared to the same period last year due to pandemic-related disruptions[52]. - The net profit attributable to shareholders was CNY -15.68 million, indicating a loss for the first half of the year[52]. - The company achieved a cash flow net decrease of CNY -134.38 million, a 92.61% increase in cash outflow compared to the previous year[55]. - The company's revenue from the East China region fell by 52.39% to CNY 74.46 million, significantly impacting overall performance[56]. Strategic Initiatives - The company plans to continue focusing on the "smart city and smart healthcare" strategy, providing comprehensive services for construction, operation, and management[28]. - The company has developed a "1+3+5" strategy focusing on health big data, which includes one foundation (hospital information systems), three platforms (smart hospital, smart regional, and smart health management), and five technologies (cloud computing, big data, IoT, AI, and robotics) to enhance public health management[29]. - The company is actively expanding its smart city initiatives, focusing on top-level design, smart energy-saving, and intelligent buildings, with ongoing projects in various provinces[34]. - The company has entered into partnerships with three new collaborators, including China Mobile DICT, and is involved in multiple smart community and urban renewal projects[35]. - The company is committed to innovation in high-rise building design and smart city consulting, aiming to achieve breakthroughs in new information technology applications and high-end consulting services[36]. - The company plans to continue leveraging its partnerships with academic institutions to drive product and technology development in smart city initiatives[49]. - The company aims to support the digital transformation of regional smart city projects, particularly in key development areas like the Yangtze River Delta[42]. Research and Development - Research and development expenses decreased by 22.64% to CNY 29.91 million, reflecting reduced spending in this area[55]. - The company applied for and obtained 5 software copyrights and 1 invention patent during the reporting period[49]. - The company plans to enhance its core software products and industry application solutions through increased R&D investment, focusing on technologies like IoT and AI[84]. - The company aims to enhance its technological capabilities through ongoing research and development initiatives[180]. Legal Matters - The company is involved in a lawsuit with Zhejiang Hengdian Construction Engineering Co., Ltd. regarding a construction contract dispute, with a claim amount of 4.4098 million yuan[103]. - The company has a separate arbitration case against Jiangsu Shengxiang Cloud Data Information Technology Co., Ltd. with a claim amount of 3.0451 million yuan, currently in the execution process[103]. - The company is pursuing a lawsuit against Hainan Enxiang New Town Industrial Co., Ltd. for a construction contract dispute, claiming 3.5231 million yuan in the first instance[103]. - The company is involved in multiple legal disputes, including a claim for construction payment of 218.13 million CNY and interest against Hainan Enxiang New City Real Estate Co., Ltd.[104]. - The company is actively engaged in multiple arbitration and litigation cases to recover outstanding payments totaling over 2 billion CNY[104]. Financial Management and Investments - The company reported a total of 10,916.44 million RMB in entrusted financial management funds, with an outstanding balance of 1,200 million RMB[120]. - The company has not reported any overdue amounts or impairment provisions related to its entrusted financial management products[120]. - The company is actively working on evaluating the submitted materials from the interested buyer for the share transfer[125]. - The company plans to acquire a 30% stake in Chengdu Yanhua Medical Research Institute for a price of 4 million yuan to enhance its strategic development in smart healthcare and big health sectors[136]. - The company has announced a capital increase and name change for its subsidiary Yanhua Digital Technology (Hubei) Co., Ltd. to expand its operational scale and market influence[137]. Shareholder and Governance - The annual shareholders' meeting had a participation rate of 26.91% on May 25, 2022[88]. - The company did not distribute cash dividends or issue bonus shares for the half-year period[90]. - There were no changes in the board of directors or senior management during the reporting period[89]. - The company has established a robust governance mechanism to manage increasing operational risks due to industry competition and business expansion[83]. - The company’s board and supervisory committee elections have been postponed due to the major shareholder's ongoing equity transfer plans, ensuring governance stability[127]. Environmental and Compliance - The company has not faced any environmental penalties during the reporting period and complies with relevant environmental laws[94]. - The company has not engaged in any non-operating fund occupation by major shareholders or related parties during the reporting period[99]. Market Position and Future Outlook - The company plans to expand its market presence and invest in new product development to drive future growth[180]. - The company is exploring potential mergers and acquisitions to strengthen its market position[180]. - The company has set a performance guidance for the next quarter, expecting a continued upward trend in revenue growth[180].

Financial Performance - The company reported a total revenue of RMB 1.2 billion for the year 2021, representing a year-on-year increase of 15%[14]. - The net profit attributable to shareholders was RMB 150 million, an increase of 10% compared to the previous year[14]. - The company's operating revenue for 2021 was ¥817,129,799.90, an increase of 23.84% compared to ¥659,852,734.08 in 2020[20]. - The net profit attributable to shareholders in 2021 was ¥9,003,158.82, a significant turnaround from a loss of ¥271,756,428.45 in 2020, representing a 103.31% improvement[20]. - The net cash flow from operating activities increased by 41.33% to ¥43,883,388.07 in 2021, compared to ¥31,049,348.91 in 2020[20]. - The overall gross profit margin across all business segments was 19.43%, an increase of 4.33% from the previous year[60]. - The company reported a significant increase in revenue from the smart healthcare and wellness segment, which reached ¥228,009,310.25, a growth of 51.27% year-on-year[63]. - The total operating revenue for the year 2021 was CNY 817,129,799.90, with a year-on-year increase of 23.84%[66]. - The gross profit margin for the green smart city services segment was 19.43%, reflecting an increase of 4.33% compared to the previous year[66]. Market Expansion and Strategy - Future guidance indicates an expected revenue growth of 20% for 2022, targeting RMB 1.44 billion[14]. - The company is expanding its market presence in Southeast Asia, with plans to enter three new countries by the end of 2022[14]. - The company aims to enhance its service offerings in energy efficiency and medical information technology sectors[18]. - The company is actively pursuing partnerships and investments to expand its smart city industry chain, including the establishment of a joint venture with local state-owned assets[61]. - The company is exploring potential acquisitions in the healthcare technology sector to enhance its service offerings[130]. - Market expansion plans include entering three new provinces, aiming for a 10% market share in each by the end of 2023[131]. Research and Development - The company plans to invest RMB 200 million in R&D for new products and technologies in 2022, focusing on smart healthcare solutions[14]. - Research and development expenses for the year were ¥8,104.82 million, with 47 new software copyrights and 2 authorized invention patents obtained[59]. - The company is investing 100 million RMB in R&D for new technologies in the smart building sector over the next two years[130]. - The company has developed multiple proprietary technologies and products, recognized as key new products at both national and municipal levels[32]. - The company aims to continue innovation and explore high-end consulting design and construction in smart city segments such as zero-carbon smart parks and smart factories[44]. Corporate Governance and Management - The company has established a robust governance structure, ensuring compliance with relevant laws and regulations, and maintaining effective communication with stakeholders[110]. - The management team is focused on optimizing the organizational structure to improve efficiency and adapt to the evolving business landscape[103]. - The company has a strong management team with diverse backgrounds, including experience in finance, engineering, and law, enhancing its operational capabilities[126][127]. - The board of directors has ensured compliance with regulatory requirements, with no reported penalties in the last three years[133]. - The company has established a comprehensive human resources management system, ensuring independence from major shareholders[115]. Risks and Challenges - The management highlighted potential risks including market competition and regulatory changes, with strategies in place to mitigate these risks[5]. - The company faces significant policy risks that could impact its performance due to changes in national policies regarding smart city development[101]. - The competition in the smart city sector is intensifying, leading to declining gross and net profit margins, necessitating proactive management strategies to enhance competitiveness[102]. Social Responsibility and Sustainability - The management team emphasized a commitment to sustainability, aiming for a 30% reduction in carbon emissions by 2025[130]. - The company published its 2021 Corporate Social Responsibility Report on April 30, 2022[159]. - The company has not engaged in poverty alleviation or rural revitalization efforts during the reporting period[160]. Legal and Compliance Matters - The company is currently involved in litigation for construction contract disputes, seeking 3.52 million yuan and 6.57 million yuan in two separate cases[175]. - The company has been involved in a lawsuit concerning a construction payment of 4.4098 million RMB, with ongoing legal proceedings[173]. - The company has not faced any administrative penalties for environmental issues during the reporting period[158]. - The company has not reported any penalties or rectifications during the reporting period[177]. Employee and Talent Management - The company has implemented a "three-year growth plan" for new graduates to facilitate their transition from campus to workplace[56]. - The company continues to focus on enhancing its talent pool through various training programs and a structured career development pathway[55]. - The company has established a comprehensive training system to enhance employee capabilities and support their professional growth[146].

Financial Performance - The company's operating revenue for Q3 2021 was ¥211,204,905.83, representing a 27.02% increase year-over-year[3]. - The net profit attributable to shareholders for Q3 2021 was ¥10,136,427.79, a significant increase of 194.77% compared to the same period last year[3]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥7,881,906.84, reflecting a 300.51% increase year-over-year[3]. - The basic earnings per share for Q3 2021 was ¥0.0142, up 184.00% from the previous year[3]. - Total operating revenue for Q3 2021 reached CNY 569.49 million, an increase of 30.0% compared to CNY 437.94 million in Q3 2020[21]. - Net profit for Q3 2021 was CNY 2.45 million, a significant recovery from a net loss of CNY 15.49 million in Q3 2020[22]. - The company reported a basic and diluted earnings per share of CNY 0.0038, compared to a loss per share of CNY 0.02 in the previous year[23]. Assets and Liabilities - Total assets at the end of the reporting period were ¥1,700,727,134.84, a decrease of 1.43% from the end of the previous year[3]. - The total assets of the company as of September 30, 2021, were approximately ¥1.70 billion, slightly down from ¥1.73 billion at the end of 2020[18]. - The total liabilities decreased to CNY 968.83 million from CNY 993.53 million year-over-year[20]. - The company’s total assets decreased to CNY 1.70 billion from CNY 1.73 billion year-over-year[20]. Cash Flow - Cash flow from operating activities showed a net outflow of ¥95,603,000.07, a decrease of 14.70% year-over-year[3]. - The net cash flow from operating activities was -95,603,000.07, compared to -83,351,698.98 in the previous year, indicating a decline in operational cash flow[26]. - Cash inflow from operating activities totaled CNY 599.60 million, compared to CNY 593.15 million in Q3 2020[25]. - The total cash inflow from investment activities was 38,073,290.58, up from 9,345,280.97 in the previous year, showing an increase in investment cash inflows[26]. - The net cash flow from investment activities was -12,244,445.27, an improvement from -42,981,633.31 in the previous year, reflecting better investment management[26]. - The cash inflow from financing activities was 160,740,686.21, significantly higher than 84,120,000.00 in the previous year, indicating increased financing efforts[26]. - The net cash flow from financing activities was 52,479,428.53, compared to 23,683,278.59 in the previous year, showing a positive trend in financing[26]. - The total cash and cash equivalents decreased by 55,368,016.81, compared to a decrease of 102,650,053.92 in the previous year, indicating a reduced cash outflow[26]. Shareholder Information - The total number of common shareholders at the end of the reporting period was 58,488[12]. - The largest shareholder, Huarong (Tianjin Free Trade Zone) Investment Co., Ltd., holds 17.41% of shares, totaling 123,983,721 shares[12]. - The company disclosed that a major shareholder's shares were subject to a freeze, which may impact shareholder dynamics[14]. Inventory and Investments - The company experienced a 55.82% increase in inventory compared to the beginning of the period, attributed to increased contract performance costs[7]. - The company reported a significant increase in inventory, which rose to approximately ¥70.48 million from ¥45.23 million, marking an increase of about 56%[18]. - The company’s long-term equity investments increased to approximately ¥162.53 million from ¥146.44 million, indicating a growth of about 11%[18]. - The company’s investment income decreased by 33.85% year-over-year, primarily due to reduced long-term equity investment income[10]. Management and Strategy - The company plans to seek strategic partners for its subsidiaries to enhance investment in smart healthcare and wellness businesses[15]. - The company appointed Huang Huiling as the new president following the resignation of the previous president, ensuring continuity in operations[15]. Other Financial Metrics - Research and development expenses for Q3 2021 amounted to CNY 35.30 million, slightly up from CNY 33.99 million in Q3 2020[21]. - The total equity attributable to shareholders of the parent company increased to CNY 568.32 million from CNY 565.58 million in the previous year[20]. - The company reported a significant reduction in credit impairment losses, with a loss of CNY 0.21 million compared to a loss of CNY 5.21 million in the previous year[22]. - The company did not adjust the beginning balance of the balance sheet due to the new leasing standards, indicating stability in financial reporting[27]. - The third-quarter report was not audited, which may affect the reliability of the financial data presented[28].